~~<i id='960C6EDD3A'><strike id='960C6EDD3A'><tt id='960C6EDD3A'><pre id='960C6EDD3A'></pre></tt></strike></i>~~

Home» focus» comprehensive

comprehensive

author：comprehensive 2025-10-02 12:17:26 Page View：1942

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Harvard's David Sinclair gets blowback over aging
Next article： Medical records are filled with copy

explore

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Boston competes with Raleigh

PatGreenhouse/GlobeStaffMORRISVILLE,N.C.—TenminutesfromtheRaleighairport,thefutureofbiotechisunderco

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Streamlined flu vaccines recommended by FDA advisory panel

AfluvaccinesyringerestsonatableatavaccinationclinicinLakewood,Calif.MarioTama/GettyImagesWhenAmerica